Led · Series C · Feb 2025

Harrison.ai develops AI-powered diagnostic products for radiology (Annalise.ai) and pathology (Franklin.ai) to assist clinicians in detecting and categorizing disease. The company aims to scale internationally across the U.S., EMEA and Asia Pacific and to expand AI automation beyond radiology and pathology. Annalise.ai has been monetized since 2022, is operational in more than 1,000 healthcare facilities, supports treatment of over 6 million patients annually, and has regulatory clearance for clinical use in 40 countries including 12 FDA clearances. The firm reports tripling contracted annual recurring revenue for its radiology offering each year for the past three years. Harrison.ai has about 200 employees and now operates in 15 countries, and plans a North American presence in Boston. Its product pipeline includes a Prostate Biopsy offering in development, expected in 2025.

Led · Series A · Jun 2022

Bare is an Australian death‑tech startup developing a single space for customers to navigate their end‑of‑life journey, covering pre‑planning, funerals, grief, and legal and estate management. Co‑founders Cale Donovan and Sam McConkey say the company is preparing to unveil that unified platform. The startup raised a $10 million Series A led by Perennial Partners and Ord Minnett Private Capital. The company says the new capital will be directed into three core components of the business as it scales. Bare has previously raised funding from investors including OIF Ventures, Athletic Ventures, Simon Griffiths and Andrew Bogut. The raise brings the company’s total funding to $15 million over the past three years.